US20070265642A1 - Patent foramen ovale (PFO) closure method and device - Google Patents

Patent foramen ovale (PFO) closure method and device Download PDF

Info

Publication number
US20070265642A1
US20070265642A1 US11/796,937 US79693707A US2007265642A1 US 20070265642 A1 US20070265642 A1 US 20070265642A1 US 79693707 A US79693707 A US 79693707A US 2007265642 A1 US2007265642 A1 US 2007265642A1
Authority
US
United States
Prior art keywords
tissue
septum
pfo
septum secundum
catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/796,937
Inventor
Andrzej Chanduszko
Steven Opolski
Carol Devellian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WL Gore and Associates Inc
Original Assignee
NMT Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NMT Medical Inc filed Critical NMT Medical Inc
Priority to US11/796,937 priority Critical patent/US20070265642A1/en
Publication of US20070265642A1 publication Critical patent/US20070265642A1/en
Assigned to W.L. GORE & ASSOCIATES, INC. reassignment W.L. GORE & ASSOCIATES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NMT MEDICAL, INC. (BY AND THROUGH JOSEPH F. FINN, JR., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF NMT MEDICAL, INC.)
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/064Surgical staples, i.e. penetrating the tissue
    • A61B17/0644Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068Surgical staplers, e.g. containing multiple staples or clamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00579Barbed implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00592Elastic or resilient implements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/0057Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
    • A61B2017/00575Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
    • A61B2017/00615Implements with an occluder on one side of the opening and holding means therefor on the other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00831Material properties
    • A61B2017/00867Material properties shape memory effect

Definitions

  • the invention relates to occlusion devices and methods for the closure of physical anomalies, like septal apertures, such as patent foramen ovale and other septal and vascular defects.
  • a patent foramen ovale as shown in FIG. 1 , is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and septum secundum 16 . However, a PFO has been shown to persist in a number of adults.
  • a PFO has no therapeutic consequence in otherwise healthy adults.
  • patients suffering a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event.
  • TIA transient ischemic attack
  • These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
  • Nonsurgical closure of PFOs has become possible with the advent of umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASD). These devices allow patients to avoid the potential side effects often associated with anticoagulation therapies.
  • septal closure devices present such drawbacks as technical complexity of implantation procedure, high complication rates (thrombus, fractures, conduction system disturbances, perforations, residual leaks), high septal profile, large masses of foreign material, and lack of anatomic conformability especially to the PFO flap-like anatomy, as most were originally designed to close ASD's, which are true holes. Additionally, some septal closure devices are complex to manufacture, which can result in lack of consistency in product performance.
  • the present invention provides a method of closing two overlapping layers of tissue in a mammalian heart, e.g., a patent foramen ovale (PFO), using a closure device that applies a compressive force to at least one of the layers of tissue.
  • the closure device may be retrievable, such that it may be removed after a period of time sufficient to allow the overlapping layers of tissue to fuse together. If necessary to sufficiently close the length of the layers of tissue, multiple closure devices may be administered.
  • the closure devices may be delivered with a catheter capable of puncturing mammalian tissue in at least one location.
  • the closure device of the present invention may take a number of different forms.
  • the closure device may have first and second ends, both of which may be capable of puncturing mammalian tissue.
  • the device may be a structure such as a ring with a gap, a folded ring, at least one grappling hook member joined to at least one curved arm by a joinder member, opposed grappling hook members joined by a central connecting member, a grappling hook member and a central connecting member, or a closure device anchor joined to a structure of sufficient diameter to hold the device in place against the overlapping layers of tissue.
  • the closure device is sized and shaped such that it extends from septum secundum in the left atrium, into the left atrium, through septum primum, into the right atrium, and to septum secundum in the right atrium.
  • Some retrievable devices include elongate tethers to facilitate their removal. Each of these devices has certain advantages, and one skilled in the art will be capable of selecting the device appropriate for a given application.
  • the ends of the closure device may also take a number of different forms.
  • at least one end may form a disc or a closure device anchor, such as a coil, hook, or corkscrew.
  • a closure device anchor such as a coil, hook, or corkscrew.
  • These end structures help to maintain the device in place.
  • One of the ends, for example the second end may take the form of a knot or a structure similarly capable of holding the device in place and applying a sufficient compressive force to the overlapping layers of tissue.
  • the end structure may be adjusted to alter the compressive force applied to the overlapping layers of tissue.
  • either or both of the first and second ends may be capable of puncturing mammalian tissue.
  • the first end of the device is a septal puncture needle.
  • Some closure devices according to the present invention are intended to puncture septum primum upon insertion into the heart.
  • such a device may be inserted into the right atrium of the heart and puncture septum primum to enter the left atrium of the heart.
  • the first end of the device may simply be deployed into the left atrium, or the first end of the device may be deployed into the left atrium and at least partially puncture septum secundum.
  • the first end may be embedded in septum secundum or may completely puncture septum secundum such that the first end extends into the right atrium.
  • the second end of the device may then be positioned against septum secundum in the right atrium, thereby providing a compressive force to the septal tissues.
  • the second end is also positioned in the left atrium while another portion of the device, such as a fold, is positioned in the right atrium, thereby compressing the septal tissues between the device.
  • some closure devices according to the present invention are intended to be inserted between the overlapping layers of tissue, e.g. through the PFO tunnel, to enter the left atrium.
  • the first end of the device is then deployed in the left atrium and the second end of the device is deployed in the right atrium, thereby providing a compressive force to the septal tissue.
  • at least one of the ends of the device may partially puncture septum secundum.
  • FIG. 1 is a diagrammatic sectional view of a Patent Foramen Ovale (PFO);
  • FIG. 2 is a view in side elevation of the PFO closure device with mechanical anchors of the present invention
  • FIGS. 3 a , 3 b and 3 c illustrate the steps in the deployment of the PFO closure device of FIG. 2 ;
  • FIG. 4 is a view in side elevation of a second embodiment of the PFO closure device with mechanical anchors of the present invention
  • FIGS. 5 a , 5 b and 5 c illustrate the steps in the deployment of the PFO closure device of FIG. 4 ;
  • FIG. 6 is a view in side elevation of a catheter and septal puncture needle used to pierce septum primum;
  • FIG. 7 is a view in side elevation of a needle anchor for PFO closure
  • FIG. 8 is a view in side elevation of a suture and anchor used for PFO closure
  • FIG. 9 is a diagram of multiple anchor placement for PFO closure
  • FIGS. 10 a , 10 b and 10 c illustrate the steps in the deployment of a rivet and suture type of PFO closure device
  • FIGS. 11 a , 11 b , 11 c and lid illustrate the steps in the deployment of a removable PFO closure device
  • FIGS. 12 a , 12 b and 12 c illustrate the steps in the deployment of a multiple hook PFO closure device
  • FIG. 13 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
  • FIG. 14 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
  • FIGS. 15 a , 15 b , and 15 c are an end face view from the right atrium, an end face view from the left atrium, and a side elevation view, respectively, of the deployed alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
  • a PFO closure device with mechanical anchors indicated generally at 18 includes opposed grappling hook members 20 and 22 connected by a central connecting member 24 .
  • the grappling hook members 20 and 22 each include two or more curved hooks.
  • three curved hooks 26 , 28 and 30 form the grappling hook member 20 and three curved hooks 32 , 34 and 36 form the grappling hook member 22 .
  • the grappling hooks 26 , 28 , 30 , 32 , 34 , and 36 extend radially from the central connecting member 24 .
  • the grappling hooks of grappling hook members 20 and 22 have the same geometry but are rotated such that each grappling hook of grappling hook member 20 is situated precisely between two opposed grappling hooks of grappling hook member 22 .
  • the angle between any two grappling hooks of grappling hook members 20 and 22 may be determined by the formula 360°/(number of hooks per grappling hook member). To fit within a catheter, these hooks may all be straightened outwardly and compressed to lie along the longitudinal axis of the central connecting member 24 . In this form, the PFO closure device extends longitudinally within a catheter 38 .
  • the catheter 38 is inserted from the right atrium 10 through the PFO tunnel, i.e. between septum primum 14 and septum secundum 16 , into the left atrium 12 .
  • the grappling hook member 20 is deployed into the left atrium.
  • the catheter 38 is drawn back into the right atrium and the grappling hooks 26 , 28 and 30 are drawn back and embedded in the left sides of septum primum and septum secundum.
  • the central connecting member 24 extends at an angle through the PFO tunnel permitting septum primum and septum secundum to be drawn to the closed position and secured by the grappling hooks 26 , 28 and 30 .
  • the catheter 38 is drawn back to permit the grappling hook member 22 to deploy, and grappling hooks 32 , 34 and 36 pierce the right side of septum primum and septum secundum.
  • the grappling hook members 20 and 22 may be formed of flexible, spring-like, bioabsorbable polymer material so as to permit movement from the compressed straight shape to the curved hook shapes following deployment from the catheter 38 .
  • the central connecting member 24 may also be formed of bioabsorbable material, such as an absorbable suture material, so the device will ultimately leave no foreign substance in either atrium.
  • the grappling hook members 20 and 22 may be formed of spring metal or of a shape memory material, such as nitinol. When the PFO closure device is not formed of bioabsorbable material, it is possible to form the device with only the grappling hook member 20 and a central connecting member 24 so that the device is repositionable and retrievable.
  • grappling hooks 26 , 28 , 30 , 32 , 34 and 36 may further include a barb to maintain the device in the septal tissue.
  • the grappling hook members 20 and 22 serve as tissue scaffolds, and are covered with a vascular material, such as polyester, biological tissue, bioresorbable polymer, or spongy polymeric material.
  • the closure device will conform, at least to some extent, to the septal tissue that it compresses.
  • the extent of this conformance depends upon the material from which the device was formed: a device formed of a spring metal or shape memory material will conform to the surrounding septal tissue to a lesser extent than one formed of a flexible, bioabsorbable polymer material.
  • FIG. 4 shows a second embodiment of a PFO closure device with mechanical anchors indicated generally at 40 .
  • This device when deployed, forms a ring hook design that terminates in two opposed, pointed ends 42 and 44 .
  • the device may be straightened to pass through a catheter 38 .
  • the catheter is caused to pierce septum primum 14 and enter the left atrium where the pointed end 42 is deployed.
  • the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end 42 in the left side of septum secundum.
  • FIG. 5 b the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end 42 in the left side of septum secundum.
  • the catheter is withdrawn to fully deploy the PFO closure device and the pointed end 44 is embedded in the right side of septum secundum to compress septum primum and septum secundum together.
  • the ring PFO closure device 40 when deployed, may include a gap that is slightly smaller than the thickness of septum secundum into which it is embedded.
  • the opposed ends 42 and 44 of the deployed PFO closure device 40 contact each other or overlap.
  • closure device 40 may take alternative forms.
  • closure devices 90 and 100 are formed as partial rings terminating in two pointed ends 92 and 94 or 102 and 104 and having at least one fold therebetween.
  • Closure devices 90 and 100 are deployed in a manner similar to that described above and shown in FIG. 5 .
  • the pointed ends 92 and 94 or 102 and 104 puncture the surface of septum secundum exposed in the left atrium and at least one of the folds contacts the surface of septum secundum exposed in the right atrium ( FIGS. 15 a and 15 b ). Septum primum and septum secundum are thus compressed between the pointed ends and at least one of the folds of the device ( FIG. 15 c ).
  • PFO closure devices 40 , 90 or 100 can be inserted until the physician is satisfied with the resultant PFO closure.
  • the PFO closure devices may be formed of flexible, bioabsorbable polymer material, spring metal, other spring-like non-bioabsorbable material, or shape memory material. The choice of material will affect the degree to which the device conforms to the surrounding septal tissue. As shown in FIGS. 4, 13 , and 14 , the PFO closure device may be a monolithic structure.
  • a PFO may also be closed with one or more sutures.
  • suture refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch.
  • suture refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch.
  • to suture a PFO closed has conventionally required the attachment of septum secundum to septum primum with a continuous stitch. This need for a continuous stitch can be eliminated by implanting sutures across the PFO using implantable suture anchors.
  • a catheter 46 is used to puncture septum primum and then septum secundum.
  • septum primum the puncture creates a hole through which the catheter can pass; in the case of septum secundum, the puncture may be a depression that does not pass through septum secundum.
  • a single puncture may be made in septum secundum as shown in FIGS. 6-8 , or, as subsequently described and shown in FIG. 9 , multiple punctures may be made. These punctures are made using a sharp pointed needle tip 48 . Following puncture to a desired depth, the catheter 46 surrounding the needle 48 is withdrawn and the needle component returns (most likely via shape memory) to its predetermined anchor-shape.
  • the anchors are most likely fabricated from a shape memory alloy, such as nitinol, although they could be made from a flexible, bioabsorbable polymer or a noble metal, each having their own advantage—no long term implant issues with bioabsorbable anchors and excellent radiopacity with anchors fabricated from a noble metal, such as platinum-iridium.
  • the remainder of the suture may be formed of any suitable material, including wire, polymeric materials, and bioabsorbable materials.
  • the suturing method includes using a standard septal puncture technique to locate and puncture septum primum. Following this, several approaches exist. One would be that the septal puncture needle would be withdrawn from the catheter and the suturing system then delivered through the catheter (the septal needle catheter would maintain position across septum primum during the exchange). Alternatively, a wire could be placed through the septal needle catheter to maintain position and the suture system could be delivered over the wire, or the septal puncture needle could become part of the suture system. Following delivery of the suture system, the proximal end of the suture may then be tied off so as to secure the system in place and keep the PFO closed. As described below for the rivet design suture system and shown in FIG.
  • the proximal end of the suture may be formed into a knot, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place.
  • Other suitable structures for the proximal end of the suture include, but are not limited to, coils, spirals, and other adjustable mechanisms. This structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple sutures may be inserted until the physician is satisfied with the PFO closure.
  • a suture 50 is delivered through the septal needle catheter following the removal of the needle.
  • a suture catheter 52 enters the left atrium through the septal needle catheter, is pulled back against septum secundum, setting the needle tip(s) 54 deep within it or through it, if it is thin enough.
  • the tip could be either radiopaque, echogenic, or both, to be visible by x-ray (fluoroscopy) and/or cardiac echo.
  • the constricting system a hypotube or a series of con-axial hypotubes in the embodiment where multiple needles are simultaneously delivered
  • the suture anchor 56 is withdrawn, allowing the suture anchor 56 to form into a pre-determined shape tissue anchor, most likely via shape memory properties.
  • the anchor 56 on the end of the suture 50 has been embedded in septum secundum and expands to anchor the suture, which passes through septum primum once the suture catheter is removed.
  • the anchor shape can be one of many different options, including but not limited to a coil, hook, corkscrew, or grappling hook.
  • an anchor can be placed entirely in the right atrium, leaving nothing but suture in the left atrium.
  • These anchors may be short strips or cylindrical rods made from a metallic or polymeric material that is biostable or bioabsorbable, or a piece of swellable foam, such as Ivalon.
  • the septal needle catheter crosses septum secundum in multiple locations simultaneously.
  • the final result as seen from the left atrium in an end face view of septum primum and septum secundum, would be as shown in FIG. 9 , where a plurality of spaced anchors 58 engage septum secundum.
  • a rivet design suture system 60 is shown in FIGS. 10 a , 10 b and 10 c .
  • a suture 62 and anchor 64 are contained within a catheter 66 , which pierces both septum secundum and septum primum.
  • the anchor 64 which is formed of a firm material, such as a metal disc, a small hook (such as the shape memory hooks previously described), or a piece of bio-absorbable polymer, is then deployed into the left atrium, and the suture 62 and catheter 66 are then pulled back as shown in FIG. 10 b to compress the two septa together.
  • the suture 62 can then be knotted with knot 68 , as shown in FIG.
  • the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place.
  • Other suitable structures for the second end of the suture include, but are not limited to, coils, spirals, other adjustable mechanisms. As shown in FIG. 10 c , this structure should apply sufficient compression to hold septum primum and septum secundum together.
  • the structure may be adjustable, such that the level of compression may be altered as necessary. Multiple rivet systems can be inserted until a physician is satisfied with the PFO closure.
  • the PFO closure device of the present invention may be formed in a manner to facilitate removal once septum primum and septum secundum are fused.
  • An exemplary removable PFO closure device 70 is deployed in the manner illustrated by FIGS. 11 a - 11 d .
  • the PFO closure device 70 may be delivered by a delivery catheter or sheath 72 and includes a grappling hook member 74 joined to a curved arm 76 by an enlarged tip joinder member 78 . At least one of the grappling hook member and curved arm of the PFO closure device may be curved relative to the other.
  • An elongate tether 80 is connected to the tip joinder member 78 and extends back through the catheter 72 .
  • the tether 80 can be coated to minimize trauma to the veins.
  • the grappling hook member 74 is passed through septum primum 14 ( FIG. 11 b ), and the grappling hook, when free of the catheter, curves in a manner convex relative to the surface of septum secundum and penetrates septum secundum 16 ( FIG. 11 c ). Then, the grappling hook is drawn back toward the catheter by the tether 80 to apply tension to the tissue causing septum secundum to be drawn into contact with septum primum. Then the curved arm 76 is deployed ( FIG. 11 d ) and curves in a manner concave relative to septum secundum so as to engage septum secundum as the catheter is drawn back.
  • the compressive force applied by the grappling hook and the curved arm hold septum primum and septum secundum tightly together.
  • the grappling hook 74 and curved arm 76 are preferably formed of shape memory material, such as nitinol, so that they respond to body temperature when deployed from the catheter 72 to form the shape shown in FIG. 11 d.
  • the catheter 72 is withdrawn and the free end of the tether 80 is attached to a button subcutaneously and allowed to remain in place for a period of time sufficient to allow the two septa to fuse together. Then the device is pulled through septum primum and into a recovery sheath by means of the tether 80 and removed.
  • the PFO closure device 70 can be deployed as shown in FIG. 11 without the tether 80 to provide a free standing device with the grappling hook 74 and arm 76 being formed to press the two septa 14 and 16 together.
  • the device may later be removed by a removal device, which grabs the joinder member 78 and draws the device through septum primum 14 and into a removal sheath.
  • the PFO closure device can include a plurality of opposed grappling hooks and curved arms radially extending in a spaced relationship from the joinder member 78 .
  • a device 82 is shown in FIG. 12 .
  • the PFO closure device includes a plurality of grappling hooks 84 and a plurality of opposed curved arms 86 which are enclosed in a delivery catheter 72 .
  • a small hole 88 is created in septum primum 14 to permit insertion of the catheter into the left atrium and the grappling hooks 84 are deployed as shown in FIG. 12 a . Then, the delivery catheter is drawn back to engage the hooks with both septum secundum and septum primum as shown in FIG.
  • the catheter is drawn away to release the curved arms 86 , which engage the two septa in opposed relationship to the grappling hooks 84 .
  • the device may have many, e.g. eight, opposed grappling hooks and curved arms.
  • the device 82 may be removed by grasping the tip joinder member 78 .
  • the device 82 may be permanently deployed by inserting the catheter through the PFO channel between septum secundum and septum primum into the left atrium to deploy the grappling hooks 84 . Then, the catheter is withdrawn back through the PFO channel to release the curved arms 86 .

Abstract

The present invention provides methods and devices for closing two overlapping layers of tissue in a mammalian heart, for example a patent foramen ovale (PFO). The closure devices may take a number of different forms and may be retrievable. In some embodiments, a device is sized and shaped to extend from septum secundum, into the left atrium, through septum primum, and into the right atrium, such that the first and second ends cooperate to provide a compressive force to the overlapping layers of tissue. In some embodiments, the closure devices may be delivered with a catheter capable of puncturing mammalian tissue.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • This Application is a Divisional of U.S. patent application Ser. No. 10/341,802, entitled Patent Foramen Ovale (PFO) Closure Method and Device, filed Jan. 14, 2003, and incorporated herein by this reference.
  • FIELD OF THE INVENTION
  • The invention relates to occlusion devices and methods for the closure of physical anomalies, like septal apertures, such as patent foramen ovale and other septal and vascular defects.
  • BACKGROUND OF THE INVENTION
  • A patent foramen ovale (PFO) as shown in FIG. 1, is a persistent, one-way, usually flap-like opening in the wall between the right atrium 10 and left atrium 12 of the heart. Since left atrial (LA) pressure is normally higher than right atrial (RA) pressure, the flap typically stays closed. Under certain conditions, however, RA pressure can exceed LA pressure creating the possibility for right to left shunting that can allow blood clots to enter the systemic circulation. In utero, the foramen ovale serves as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and septum secundum 16. However, a PFO has been shown to persist in a number of adults.
  • The cause of ischemic stroke remains cryptogenic (of unknown origin) in approximately 40% of cases. Especially in young patients, paradoxical embolism via a PFO is considered in the diagnosis. While there is currently no proof for a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is good evidence that patients with PFO and paradoxical embolism are at increased risk for future, recurrent cerebrovascular events.
  • The presence of a PFO has no therapeutic consequence in otherwise healthy adults. In contrast, patients suffering a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event. These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs.
  • In certain cases, such as when anticoagulation is contraindicated, surgery may be used to close the PFO. To suture a PFO closed requires attachment of septum secundum to septum primum with either an interrupted or a continuous stitch, which is the common way a surgeon shuts the PFO under direct visualization.
  • Nonsurgical closure of PFOs has become possible with the advent of umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASD). These devices allow patients to avoid the potential side effects often associated with anticoagulation therapies.
  • Currently available designs of septal closure devices, however, present such drawbacks as technical complexity of implantation procedure, high complication rates (thrombus, fractures, conduction system disturbances, perforations, residual leaks), high septal profile, large masses of foreign material, and lack of anatomic conformability especially to the PFO flap-like anatomy, as most were originally designed to close ASD's, which are true holes. Additionally, some septal closure devices are complex to manufacture, which can result in lack of consistency in product performance.
  • SUMMARY OF THE INVENTION
  • In one aspect, the present invention provides a method of closing two overlapping layers of tissue in a mammalian heart, e.g., a patent foramen ovale (PFO), using a closure device that applies a compressive force to at least one of the layers of tissue. The closure device may be retrievable, such that it may be removed after a period of time sufficient to allow the overlapping layers of tissue to fuse together. If necessary to sufficiently close the length of the layers of tissue, multiple closure devices may be administered. The closure devices may be delivered with a catheter capable of puncturing mammalian tissue in at least one location.
  • The closure device of the present invention may take a number of different forms. For example, the closure device may have first and second ends, both of which may be capable of puncturing mammalian tissue. The device may be a structure such as a ring with a gap, a folded ring, at least one grappling hook member joined to at least one curved arm by a joinder member, opposed grappling hook members joined by a central connecting member, a grappling hook member and a central connecting member, or a closure device anchor joined to a structure of sufficient diameter to hold the device in place against the overlapping layers of tissue. In some embodiments of the present invention, the closure device is sized and shaped such that it extends from septum secundum in the left atrium, into the left atrium, through septum primum, into the right atrium, and to septum secundum in the right atrium. Some retrievable devices include elongate tethers to facilitate their removal. Each of these devices has certain advantages, and one skilled in the art will be capable of selecting the device appropriate for a given application.
  • The ends of the closure device may also take a number of different forms. For example, at least one end may form a disc or a closure device anchor, such as a coil, hook, or corkscrew. These end structures help to maintain the device in place. One of the ends, for example the second end, may take the form of a knot or a structure similarly capable of holding the device in place and applying a sufficient compressive force to the overlapping layers of tissue. In some embodiments, the end structure may be adjusted to alter the compressive force applied to the overlapping layers of tissue. As previously mentioned, either or both of the first and second ends may be capable of puncturing mammalian tissue. In some embodiments, the first end of the device is a septal puncture needle.
  • The closure device may be formed of any of several materials, such as flexible polymer materials, bioabsorbable materials, shape memory materials, metals, noble metals, or swellable foams. In particular embodiments, the device includes nitinol. Some of the devices are formed from a single piece of material, while others are formed from multiple pieces of material joined together.
  • Some closure devices according to the present invention are intended to puncture septum primum upon insertion into the heart. For example, such a device may be inserted into the right atrium of the heart and puncture septum primum to enter the left atrium of the heart. At this point, the first end of the device may simply be deployed into the left atrium, or the first end of the device may be deployed into the left atrium and at least partially puncture septum secundum. In those embodiments where the first end of the device at least partially punctures septum secundum, the first end may be embedded in septum secundum or may completely puncture septum secundum such that the first end extends into the right atrium. The second end of the device may then be positioned against septum secundum in the right atrium, thereby providing a compressive force to the septal tissues. In other embodiments, the second end is also positioned in the left atrium while another portion of the device, such as a fold, is positioned in the right atrium, thereby compressing the septal tissues between the device.
  • Alternatively, some closure devices according to the present invention are intended to be inserted between the overlapping layers of tissue, e.g. through the PFO tunnel, to enter the left atrium. In these embodiments, the first end of the device is then deployed in the left atrium and the second end of the device is deployed in the right atrium, thereby providing a compressive force to the septal tissue. As discussed above, at least one of the ends of the device may partially puncture septum secundum.
  • These and other features will become readily apparent from the following detailed description wherein embodiments of the invention are shown and described by way of illustration.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a diagrammatic sectional view of a Patent Foramen Ovale (PFO);
  • FIG. 2 is a view in side elevation of the PFO closure device with mechanical anchors of the present invention;
  • FIGS. 3 a, 3 b and 3 c illustrate the steps in the deployment of the PFO closure device of FIG. 2;
  • FIG. 4 is a view in side elevation of a second embodiment of the PFO closure device with mechanical anchors of the present invention;
  • FIGS. 5 a, 5 b and 5 c illustrate the steps in the deployment of the PFO closure device of FIG. 4;
  • FIG. 6 is a view in side elevation of a catheter and septal puncture needle used to pierce septum primum;
  • FIG. 7 is a view in side elevation of a needle anchor for PFO closure;
  • FIG. 8 is a view in side elevation of a suture and anchor used for PFO closure;
  • FIG. 9 is a diagram of multiple anchor placement for PFO closure;
  • FIGS. 10 a, 10 b and 10 c illustrate the steps in the deployment of a rivet and suture type of PFO closure device;
  • FIGS. 11 a, 11 b, 11 c and lid illustrate the steps in the deployment of a removable PFO closure device;
  • FIGS. 12 a, 12 b and 12 c illustrate the steps in the deployment of a multiple hook PFO closure device;
  • FIG. 13 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention;
  • FIG. 14 is a view in side elevation of an alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention; and
  • FIGS. 15 a, 15 b, and 15 c are an end face view from the right atrium, an end face view from the left atrium, and a side elevation view, respectively, of the deployed alternative structure of the second embodiment of the PFO closure device with mechanical anchors of the present invention.
  • DETAILED DESCRIPTION
  • Referring to FIGS. 2 and 3, a PFO closure device with mechanical anchors indicated generally at 18 includes opposed grappling hook members 20 and 22 connected by a central connecting member 24. When the PFO closure device 18 is deployed, the grappling hook members 20 and 22 each include two or more curved hooks. In FIGS. 2 and 3, three curved hooks 26, 28 and 30 form the grappling hook member 20 and three curved hooks 32, 34 and 36 form the grappling hook member 22. As shown in FIG. 2, the grappling hooks 26, 28, 30, 32, 34, and 36 extend radially from the central connecting member 24. The grappling hooks of grappling hook members 20 and 22 have the same geometry but are rotated such that each grappling hook of grappling hook member 20 is situated precisely between two opposed grappling hooks of grappling hook member 22. The angle between any two grappling hooks of grappling hook members 20 and 22 may be determined by the formula 360°/(number of hooks per grappling hook member). To fit within a catheter, these hooks may all be straightened outwardly and compressed to lie along the longitudinal axis of the central connecting member 24. In this form, the PFO closure device extends longitudinally within a catheter 38.
  • To deploy the PFO closure device 18, the catheter 38 is inserted from the right atrium 10 through the PFO tunnel, i.e. between septum primum 14 and septum secundum 16, into the left atrium 12. As shown in FIG. 3 a, the grappling hook member 20 is deployed into the left atrium. Next, as shown in FIG. 3b, the catheter 38 is drawn back into the right atrium and the grappling hooks 26, 28 and 30 are drawn back and embedded in the left sides of septum primum and septum secundum. The central connecting member 24 extends at an angle through the PFO tunnel permitting septum primum and septum secundum to be drawn to the closed position and secured by the grappling hooks 26, 28 and 30. Finally, as shown in FIG. 3 c, the catheter 38 is drawn back to permit the grappling hook member 22 to deploy, and grappling hooks 32, 34 and 36 pierce the right side of septum primum and septum secundum.
  • The grappling hook members 20 and 22 may be formed of flexible, spring-like, bioabsorbable polymer material so as to permit movement from the compressed straight shape to the curved hook shapes following deployment from the catheter 38. The central connecting member 24 may also be formed of bioabsorbable material, such as an absorbable suture material, so the device will ultimately leave no foreign substance in either atrium. Alternatively, the grappling hook members 20 and 22 may be formed of spring metal or of a shape memory material, such as nitinol. When the PFO closure device is not formed of bioabsorbable material, it is possible to form the device with only the grappling hook member 20 and a central connecting member 24 so that the device is repositionable and retrievable. When the device is made of a bioabsorbable material or is not intended to be retrievable, the ends of grappling hooks 26, 28, 30, 32, 34 and 36 may further include a barb to maintain the device in the septal tissue. In some embodiments, the grappling hook members 20 and 22 serve as tissue scaffolds, and are covered with a vascular material, such as polyester, biological tissue, bioresorbable polymer, or spongy polymeric material.
  • As shown in FIG. 3, the closure device will conform, at least to some extent, to the septal tissue that it compresses. The extent of this conformance depends upon the material from which the device was formed: a device formed of a spring metal or shape memory material will conform to the surrounding septal tissue to a lesser extent than one formed of a flexible, bioabsorbable polymer material.
  • FIG. 4 shows a second embodiment of a PFO closure device with mechanical anchors indicated generally at 40. This device, when deployed, forms a ring hook design that terminates in two opposed, pointed ends 42 and 44. The device may be straightened to pass through a catheter 38. To deploy the device as shown in FIGS. 5 a, 5 b and 5 c, the catheter is caused to pierce septum primum 14 and enter the left atrium where the pointed end 42 is deployed. Then, as shown in FIG. 5 b, the catheter is drawn back through septum primum to draw the device through septum primum and embed the pointed end 42 in the left side of septum secundum. Finally, as shown in FIG. 5 c, the catheter is withdrawn to fully deploy the PFO closure device and the pointed end 44 is embedded in the right side of septum secundum to compress septum primum and septum secundum together. As shown in FIGS. 4 and 5, the ring PFO closure device 40, when deployed, may include a gap that is slightly smaller than the thickness of septum secundum into which it is embedded. In some embodiments, the opposed ends 42 and 44 of the deployed PFO closure device 40 contact each other or overlap.
  • As shown in FIGS. 13 and 14, closure device 40 may take alternative forms. For example, closure devices 90 and 100 are formed as partial rings terminating in two pointed ends 92 and 94 or 102 and 104 and having at least one fold therebetween. Closure devices 90 and 100 are deployed in a manner similar to that described above and shown in FIG. 5. When deployed, the pointed ends 92 and 94 or 102 and 104 puncture the surface of septum secundum exposed in the left atrium and at least one of the folds contacts the surface of septum secundum exposed in the right atrium (FIGS. 15 a and 15 b). Septum primum and septum secundum are thus compressed between the pointed ends and at least one of the folds of the device (FIG. 15 c).
  • Multiple PFO closure devices 40, 90 or 100 can be inserted until the physician is satisfied with the resultant PFO closure. Again, the PFO closure devices may be formed of flexible, bioabsorbable polymer material, spring metal, other spring-like non-bioabsorbable material, or shape memory material. The choice of material will affect the degree to which the device conforms to the surrounding septal tissue. As shown in FIGS. 4, 13, and 14, the PFO closure device may be a monolithic structure.
  • A PFO may also be closed with one or more sutures. As used in the art and indicated in the Figures, “suture” refers to a single connection used to hold two pieces of material or tissue together and need not be a continuous stitch. However, to suture a PFO closed has conventionally required the attachment of septum secundum to septum primum with a continuous stitch. This need for a continuous stitch can be eliminated by implanting sutures across the PFO using implantable suture anchors. As shown in FIGS. 6 and 7, a catheter 46 is used to puncture septum primum and then septum secundum. In the case of septum primum, the puncture creates a hole through which the catheter can pass; in the case of septum secundum, the puncture may be a depression that does not pass through septum secundum. A single puncture may be made in septum secundum as shown in FIGS. 6-8, or, as subsequently described and shown in FIG. 9, multiple punctures may be made. These punctures are made using a sharp pointed needle tip 48. Following puncture to a desired depth, the catheter 46 surrounding the needle 48 is withdrawn and the needle component returns (most likely via shape memory) to its predetermined anchor-shape.
  • The anchors are most likely fabricated from a shape memory alloy, such as nitinol, although they could be made from a flexible, bioabsorbable polymer or a noble metal, each having their own advantage—no long term implant issues with bioabsorbable anchors and excellent radiopacity with anchors fabricated from a noble metal, such as platinum-iridium. The remainder of the suture may be formed of any suitable material, including wire, polymeric materials, and bioabsorbable materials.
  • The suturing method includes using a standard septal puncture technique to locate and puncture septum primum. Following this, several approaches exist. One would be that the septal puncture needle would be withdrawn from the catheter and the suturing system then delivered through the catheter (the septal needle catheter would maintain position across septum primum during the exchange). Alternatively, a wire could be placed through the septal needle catheter to maintain position and the suture system could be delivered over the wire, or the septal puncture needle could become part of the suture system. Following delivery of the suture system, the proximal end of the suture may then be tied off so as to secure the system in place and keep the PFO closed. As described below for the rivet design suture system and shown in FIG. 10 c, the proximal end of the suture may be formed into a knot, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the proximal end of the suture include, but are not limited to, coils, spirals, and other adjustable mechanisms. This structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple sutures may be inserted until the physician is satisfied with the PFO closure.
  • In FIG. 8, a suture 50 is delivered through the septal needle catheter following the removal of the needle. A suture catheter 52 enters the left atrium through the septal needle catheter, is pulled back against septum secundum, setting the needle tip(s) 54 deep within it or through it, if it is thin enough. The tip could be either radiopaque, echogenic, or both, to be visible by x-ray (fluoroscopy) and/or cardiac echo. Once proper position is determined, the constricting system (a hypotube or a series of con-axial hypotubes in the embodiment where multiple needles are simultaneously delivered) is withdrawn, allowing the suture anchor 56 to form into a pre-determined shape tissue anchor, most likely via shape memory properties. The anchor 56 on the end of the suture 50 has been embedded in septum secundum and expands to anchor the suture, which passes through septum primum once the suture catheter is removed. The anchor shape can be one of many different options, including but not limited to a coil, hook, corkscrew, or grappling hook.
  • In those cases where a true puncture through septum secundum can be made, an anchor can be placed entirely in the right atrium, leaving nothing but suture in the left atrium. These anchors may be short strips or cylindrical rods made from a metallic or polymeric material that is biostable or bioabsorbable, or a piece of swellable foam, such as Ivalon.
  • In another embodiment, the septal needle catheter crosses septum secundum in multiple locations simultaneously. In this embodiment, the final result, as seen from the left atrium in an end face view of septum primum and septum secundum, would be as shown in FIG. 9, where a plurality of spaced anchors 58 engage septum secundum.
  • A rivet design suture system 60 is shown in FIGS. 10 a, 10 b and 10 c. Here a suture 62 and anchor 64 are contained within a catheter 66, which pierces both septum secundum and septum primum. The anchor 64, which is formed of a firm material, such as a metal disc, a small hook (such as the shape memory hooks previously described), or a piece of bio-absorbable polymer, is then deployed into the left atrium, and the suture 62 and catheter 66 are then pulled back as shown in FIG. 10 b to compress the two septa together. The suture 62 can then be knotted with knot 68, as shown in FIG. 10 c, to secure the system 60 in place to keep the PFO closed, i.e. the end of the suture may be formed into a structure having a diameter larger than that of the catheter used to puncture septum primum so as to ensure that the suture system remains in place. Other suitable structures for the second end of the suture include, but are not limited to, coils, spirals, other adjustable mechanisms. As shown in FIG. 10 c, this structure should apply sufficient compression to hold septum primum and septum secundum together. The structure may be adjustable, such that the level of compression may be altered as necessary. Multiple rivet systems can be inserted until a physician is satisfied with the PFO closure.
  • The PFO closure device of the present invention may be formed in a manner to facilitate removal once septum primum and septum secundum are fused. An exemplary removable PFO closure device 70 is deployed in the manner illustrated by FIGS. 11 a-11 d. The PFO closure device 70 may be delivered by a delivery catheter or sheath 72 and includes a grappling hook member 74 joined to a curved arm 76 by an enlarged tip joinder member 78. At least one of the grappling hook member and curved arm of the PFO closure device may be curved relative to the other. An elongate tether 80 is connected to the tip joinder member 78 and extends back through the catheter 72. The tether 80 can be coated to minimize trauma to the veins.
  • To deploy the removable PFO closure device 70 according to one embodiment of the invention, the grappling hook member 74 is passed through septum primum 14 (FIG. 11 b), and the grappling hook, when free of the catheter, curves in a manner convex relative to the surface of septum secundum and penetrates septum secundum 16 (FIG. 11 c). Then, the grappling hook is drawn back toward the catheter by the tether 80 to apply tension to the tissue causing septum secundum to be drawn into contact with septum primum. Then the curved arm 76 is deployed (FIG. 11 d) and curves in a manner concave relative to septum secundum so as to engage septum secundum as the catheter is drawn back. The compressive force applied by the grappling hook and the curved arm hold septum primum and septum secundum tightly together. The grappling hook 74 and curved arm 76 are preferably formed of shape memory material, such as nitinol, so that they respond to body temperature when deployed from the catheter 72 to form the shape shown in FIG. 11 d.
  • Once the PFO closure device 70 is in place, the catheter 72 is withdrawn and the free end of the tether 80 is attached to a button subcutaneously and allowed to remain in place for a period of time sufficient to allow the two septa to fuse together. Then the device is pulled through septum primum and into a recovery sheath by means of the tether 80 and removed.
  • The PFO closure device 70 can be deployed as shown in FIG. 11 without the tether 80 to provide a free standing device with the grappling hook 74 and arm 76 being formed to press the two septa 14 and 16 together. The device may later be removed by a removal device, which grabs the joinder member 78 and draws the device through septum primum 14 and into a removal sheath.
  • Instead of a single opposed grappling hook 74 and curved arm 76, the PFO closure device can include a plurality of opposed grappling hooks and curved arms radially extending in a spaced relationship from the joinder member 78. Such a device 82 is shown in FIG. 12. Here, the PFO closure device includes a plurality of grappling hooks 84 and a plurality of opposed curved arms 86 which are enclosed in a delivery catheter 72. A small hole 88 is created in septum primum 14 to permit insertion of the catheter into the left atrium and the grappling hooks 84 are deployed as shown in FIG. 12 a. Then, the delivery catheter is drawn back to engage the hooks with both septum secundum and septum primum as shown in FIG. 12 b. Next, as shown in FIG. 12 c, the catheter is drawn away to release the curved arms 86, which engage the two septa in opposed relationship to the grappling hooks 84. The device may have many, e.g. eight, opposed grappling hooks and curved arms. As in the case of the PFO closure device 70, the device 82 may be removed by grasping the tip joinder member 78.
  • The device 82 may be permanently deployed by inserting the catheter through the PFO channel between septum secundum and septum primum into the left atrium to deploy the grappling hooks 84. Then, the catheter is withdrawn back through the PFO channel to release the curved arms 86.
  • Having described embodiments of the present invention, it should be apparent that the invention is capable of other and different embodiments and may be modified in various respects, all without departing from the scope of the invention as defined by the appended claims. Accordingly, the foregoing drawings and description are to be regarded as illustrative in nature and not in a restrictive or limiting sense.

Claims (19)

1. A device for closing two overlapping layers of septum primum and septum secundum dividing a left atrium and a right atrium in a mammalian heart, said device having first and second ends, wherein said device is sized and shaped to extend from septum secundum, into the left atrium, through septum primum, and into the right atrium, said first and second ends cooperating to provide a compressive force to the overlapping layers of tissue.
2. The device of claim 1, wherein said first end is embedded in, and does not extend through, septum secundum.
3. The device of claim 2, wherein said first end is formed into a coil, hook, corkscrew, or other anchor.
4. The device of claim 1, wherein said first end includes a material selected from the group consisting of bioresorbable materials, noble metals, shape memory materials, metals, polymeric materials, and swellable foams.
5. The device of claim 4, wherein said shape memory material includes nitinol.
6. The device of claim 1, wherein said first end includes a septal puncture needle capable of puncturing mammalian tissue.
7. The device of claim 1, further comprising a catheter containing said device in an elongated, low-profile form, said first end being expandable to form an anchor and said second end being adjustable to alter a compressive force applied to the overlapping layers of tissue.
8. The device of claim 1, wherein said device is sized and shaped to further extend to septum secundum in the right atrium.
9. The device of claim 8, wherein said device includes a ring with a gap terminating in first and second opposed, pointed ends for puncturing mammalian tissue.
10. The device of claim 9, wherein said device includes a material selected from the group consisting of flexible polymers, bioabsorbable materials, spring metals, and shape memory materials.
11. The device of claim 10, wherein said device includes nitinol.
12. The device of claim 9, wherein said device consists essentially of a monolithic partial ring.
13. The device of claim 9, wherein said device includes a gap slightly smaller than the thickness of the overlapping layers of tissue to which it is connected.
14. The device of claim 9, wherein said device includes a gap slightly smaller than the thickness of septum secundum.
15. The device of claim 9, wherein said first and second ends overlap each other.
16. The device of claim 1, wherein said device includes a partial ring with first and second ends and at least one fold therebetween.
17. The device of claim 16, wherein said at least one fold cooperates with said first and second ends to apply a compressive force to said overlapping layers of tissue.
18. The device of claim 16, wherein said device consists essentially of a monolithic partial ring.
19. The device of claim 1, wherein said device is sized and shaped to further contact the surfaces of septum primum exposed in both the left and right atria.
US11/796,937 2002-01-14 2007-04-30 Patent foramen ovale (PFO) closure method and device Abandoned US20070265642A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/796,937 US20070265642A1 (en) 2002-01-14 2007-04-30 Patent foramen ovale (PFO) closure method and device

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34733602P 2002-01-14 2002-01-14
US10/341,802 US7220265B2 (en) 2002-01-14 2003-01-14 Patent foramen ovale (PFO) closure method and device
US11/796,937 US20070265642A1 (en) 2002-01-14 2007-04-30 Patent foramen ovale (PFO) closure method and device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/341,802 Division US7220265B2 (en) 2002-01-14 2003-01-14 Patent foramen ovale (PFO) closure method and device

Publications (1)

Publication Number Publication Date
US20070265642A1 true US20070265642A1 (en) 2007-11-15

Family

ID=23363283

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/341,802 Expired - Fee Related US7220265B2 (en) 2002-01-14 2003-01-14 Patent foramen ovale (PFO) closure method and device
US11/796,937 Abandoned US20070265642A1 (en) 2002-01-14 2007-04-30 Patent foramen ovale (PFO) closure method and device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/341,802 Expired - Fee Related US7220265B2 (en) 2002-01-14 2003-01-14 Patent foramen ovale (PFO) closure method and device

Country Status (6)

Country Link
US (2) US7220265B2 (en)
EP (1) EP1471835A4 (en)
JP (1) JP2005525843A (en)
AU (1) AU2003210510A1 (en)
CA (1) CA2471871A1 (en)
WO (1) WO2003059152A2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100234878A1 (en) * 2009-03-16 2010-09-16 Cook Incorporated Closure device with string retractable umbrella
US8369930B2 (en) 2009-06-16 2013-02-05 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US9259290B2 (en) 2009-06-08 2016-02-16 MRI Interventions, Inc. MRI-guided surgical systems with proximity alerts
US9375218B2 (en) 2006-05-03 2016-06-28 Datascope Corp. Systems and methods of tissue closure
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
US20210205006A1 (en) * 2020-01-07 2021-07-08 Virender K. Sharma Methods and Devices for Endoscopic Resection
US11653928B2 (en) 2018-03-28 2023-05-23 Datascope Corp. Device for atrial appendage exclusion

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949116B2 (en) 1996-05-08 2005-09-27 Carag Ag Device for plugging an opening such as in a wall of a hollow or tubular organ including biodegradable elements
WO1998007375A1 (en) * 1996-08-22 1998-02-26 The Trustees Of Columbia University Endovascular flexible stapling device
US6613059B2 (en) 1999-03-01 2003-09-02 Coalescent Surgical, Inc. Tissue connector apparatus and methods
US8118822B2 (en) 1999-03-01 2012-02-21 Medtronic, Inc. Bridge clip tissue connector apparatus and methods
US6926730B1 (en) 2000-10-10 2005-08-09 Medtronic, Inc. Minimally invasive valve repair procedure and apparatus
US6551332B1 (en) 2000-03-31 2003-04-22 Coalescent Surgical, Inc. Multiple bias surgical fastener
US6440152B1 (en) * 2000-07-28 2002-08-27 Microvena Corporation Defect occluder release assembly and method
US8083768B2 (en) 2000-12-14 2011-12-27 Ensure Medical, Inc. Vascular plug having composite construction
US6896692B2 (en) 2000-12-14 2005-05-24 Ensure Medical, Inc. Plug with collet and apparatus and method for delivering such plugs
US6890343B2 (en) 2000-12-14 2005-05-10 Ensure Medical, Inc. Plug with detachable guidewire element and methods for use
US6846319B2 (en) 2000-12-14 2005-01-25 Core Medical, Inc. Devices for sealing openings through tissue and apparatus and methods for delivering them
US6623509B2 (en) 2000-12-14 2003-09-23 Core Medical, Inc. Apparatus and methods for sealing vascular punctures
US7338514B2 (en) 2001-06-01 2008-03-04 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods and tools, and related methods of use
US7288105B2 (en) 2001-08-01 2007-10-30 Ev3 Endovascular, Inc. Tissue opening occluder
US20050267495A1 (en) * 2004-05-17 2005-12-01 Gateway Medical, Inc. Systems and methods for closing internal tissue defects
US20060052821A1 (en) 2001-09-06 2006-03-09 Ovalis, Inc. Systems and methods for treating septal defects
US6776784B2 (en) 2001-09-06 2004-08-17 Core Medical, Inc. Clip apparatus for closing septal defects and methods of use
US6702835B2 (en) 2001-09-07 2004-03-09 Core Medical, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US20070112338A1 (en) * 2005-11-01 2007-05-17 Microfabrica Inc. Microdevices for tissue approximation and retention, methods for using, and methods for making
US20070198038A1 (en) * 2001-12-03 2007-08-23 Cohen Adam L Microdevices for Tissue Approximation and Retention, Methods for Using, and Methods for Making
US7318833B2 (en) 2001-12-19 2008-01-15 Nmt Medical, Inc. PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US20030130621A1 (en) * 2002-01-04 2003-07-10 Bryan Vincent E. Spinal needle system
WO2003082076A2 (en) 2002-03-25 2003-10-09 Nmt Medical, Inc. Patent foramen ovale (pfo) closure clips
US7976564B2 (en) 2002-05-06 2011-07-12 St. Jude Medical, Cardiology Division, Inc. PFO closure devices and related methods of use
WO2003103476A2 (en) 2002-06-05 2003-12-18 Nmt Medical, Inc. Patent foramen ovale (pfo) closure device with radial and circumferential support
US8066724B2 (en) * 2002-09-12 2011-11-29 Medtronic, Inc. Anastomosis apparatus and methods
US20110092988A1 (en) * 2002-10-29 2011-04-21 Microfabrica Inc. Microdevices for Tissue Approximation and Retention, Methods for Using, and Methods for Making
US8454652B1 (en) 2002-10-29 2013-06-04 Adam L. Cohen Releasable tissue anchoring device, methods for using, and methods for making
EP1572003B1 (en) 2002-12-09 2017-03-08 W.L. Gore & Associates, Inc. Septal closure devices
US20040143294A1 (en) * 2003-01-22 2004-07-22 Cardia, Inc. Septal stabilization device
US7780700B2 (en) 2003-02-04 2010-08-24 ev3 Endovascular, Inc Patent foramen ovale closure system
US8021359B2 (en) 2003-02-13 2011-09-20 Coaptus Medical Corporation Transseptal closure of a patent foramen ovale and other cardiac defects
US8021362B2 (en) 2003-03-27 2011-09-20 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
US6939348B2 (en) * 2003-03-27 2005-09-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7293562B2 (en) 2003-03-27 2007-11-13 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7972330B2 (en) 2003-03-27 2011-07-05 Terumo Kabushiki Kaisha Methods and apparatus for closing a layered tissue defect
WO2004087235A2 (en) 2003-03-27 2004-10-14 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
US7165552B2 (en) 2003-03-27 2007-01-23 Cierra, Inc. Methods and apparatus for treatment of patent foramen ovale
US20040267306A1 (en) 2003-04-11 2004-12-30 Velocimed, L.L.C. Closure devices, related delivery methods, and related methods of use
US8372112B2 (en) 2003-04-11 2013-02-12 St. Jude Medical, Cardiology Division, Inc. Closure devices, related delivery methods, and related methods of use
US7122043B2 (en) 2003-05-19 2006-10-17 Stout Medical Group, L.P. Tissue distention device and related methods for therapeutic intervention
US8480706B2 (en) 2003-07-14 2013-07-09 W.L. Gore & Associates, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
ES2428967T3 (en) 2003-07-14 2013-11-12 W.L. Gore & Associates, Inc. Oval foramen tubular permeable closure device (FOP) with retention system
US9861346B2 (en) 2003-07-14 2018-01-09 W. L. Gore & Associates, Inc. Patent foramen ovale (PFO) closure device with linearly elongating petals
WO2005034763A1 (en) * 2003-09-11 2005-04-21 Nmt Medical, Inc. Devices, systems, and methods for suturing tissue
WO2005027753A1 (en) 2003-09-19 2005-03-31 St. Jude Medical, Inc. Apparatus and methods for tissue gathering and securing
US8394114B2 (en) 2003-09-26 2013-03-12 Medtronic, Inc. Surgical connection apparatus and methods
US20050125032A1 (en) * 2003-10-10 2005-06-09 Whisenant Brian K. Patent foramen ovale (PFO) closure devices, delivery apparatus and related methods and systems
US20050192627A1 (en) * 2003-10-10 2005-09-01 Whisenant Brian K. Patent foramen ovale closure devices, delivery apparatus and related methods and systems
US7361183B2 (en) 2003-10-17 2008-04-22 Ensure Medical, Inc. Locator and delivery device and method of use
US8852229B2 (en) 2003-10-17 2014-10-07 Cordis Corporation Locator and closure device and method of use
DE602004009335T2 (en) * 2003-10-24 2008-07-03 ev3 Endovascular, Inc., Plymouth CLOSING SYSTEM FOR OPEN FORMS OVAL
US8292910B2 (en) 2003-11-06 2012-10-23 Pressure Products Medical Supplies, Inc. Transseptal puncture apparatus
US7666203B2 (en) 2003-11-06 2010-02-23 Nmt Medical, Inc. Transseptal puncture apparatus
US7056286B2 (en) 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
US7879047B2 (en) * 2003-12-10 2011-02-01 Medtronic, Inc. Surgical connection apparatus and methods
CA2553940A1 (en) 2004-01-30 2005-08-18 Nmt Medical, Inc. Devices, systems, and methods for closure of cardiac openings
JP2007526087A (en) 2004-03-03 2007-09-13 エヌエムティー メディカル, インコーポレイティッド Delivery / recovery system for septal occluder
US9713465B1 (en) * 2004-04-19 2017-07-25 Granit Medical Innovation Llc Surgical closure device and associated method
WO2005110240A1 (en) 2004-05-07 2005-11-24 Nmt Medical, Inc. Catching mechanisms for tubular septal occluder
US7367975B2 (en) 2004-06-21 2008-05-06 Cierra, Inc. Energy based devices and methods for treatment of anatomic tissue defects
US7722629B2 (en) * 2004-10-29 2010-05-25 Jeffrey W. Chambers, M.D. System and method for catheter-based septal defect repair
US20060106420A1 (en) * 2004-11-12 2006-05-18 Medtronic Vascular, Inc. Patch for treating a septal defect
US8920434B2 (en) 2005-03-02 2014-12-30 St. Jude Medical, Cardiology Division, Inc. Remote body tissue engaging methods and apparatus
US20060241687A1 (en) * 2005-03-16 2006-10-26 Glaser Erik N Septal occluder with pivot arms and articulating joints
US20060217760A1 (en) * 2005-03-17 2006-09-28 Widomski David R Multi-strand septal occluder
US8372113B2 (en) * 2005-03-24 2013-02-12 W.L. Gore & Associates, Inc. Curved arm intracardiac occluder
US7321798B2 (en) * 2005-03-31 2008-01-22 Medtronic, Inc. Trans-septal/trans-myocardial ventricular pacing lead
JP5033787B2 (en) 2005-04-11 2012-09-26 テルモ株式会社 Method and apparatus for effecting closure of a lamellar tissue defect
US8926654B2 (en) 2005-05-04 2015-01-06 Cordis Corporation Locator and closure device and method of use
US8088144B2 (en) 2005-05-04 2012-01-03 Ensure Medical, Inc. Locator and closure device and method of use
EP1887941B1 (en) * 2005-06-02 2009-11-11 Cordis Corporation Patent foramen ovale closure device
US20070005079A1 (en) * 2005-06-30 2007-01-04 David Zarbatany System, apparatus, and method for repairing septal defects
US8579936B2 (en) 2005-07-05 2013-11-12 ProMed, Inc. Centering of delivery devices with respect to a septal defect
AU2006269384B2 (en) * 2005-07-07 2012-03-29 Cardinal Health 529, Llc Patent foramen ovale closure device with steerable delivery system
US8062309B2 (en) * 2005-08-19 2011-11-22 Boston Scientific Scimed, Inc. Defect occlusion apparatus, system, and method
US7998095B2 (en) * 2005-08-19 2011-08-16 Boston Scientific Scimed, Inc. Occlusion device
US7824397B2 (en) 2005-08-19 2010-11-02 Boston Scientific Scimed, Inc. Occlusion apparatus
US7766906B2 (en) * 2005-08-19 2010-08-03 Boston Scientific Scimed, Inc. Occlusion apparatus
US7837619B2 (en) * 2005-08-19 2010-11-23 Boston Scientific Scimed, Inc. Transeptal apparatus, system, and method
US20070185530A1 (en) * 2005-09-01 2007-08-09 Chao Chin-Chen Patent foramen ovale closure method
US7846179B2 (en) 2005-09-01 2010-12-07 Ovalis, Inc. Suture-based systems and methods for treating septal defects
US7797056B2 (en) 2005-09-06 2010-09-14 Nmt Medical, Inc. Removable intracardiac RF device
US9259267B2 (en) 2005-09-06 2016-02-16 W.L. Gore & Associates, Inc. Devices and methods for treating cardiac tissue
US10143456B2 (en) * 2005-10-07 2018-12-04 Alex Javois Left atrial appendage occlusion device
US20070100324A1 (en) * 2005-10-17 2007-05-03 Coaptus Medical Corporation Systems and methods for applying vacuum to a patient, including via a disposable liquid collection unit
US7850712B2 (en) 2005-11-15 2010-12-14 Ethicon Endo-Surgery, Inc. Self-shielding suture anchor
US20070167981A1 (en) 2005-12-22 2007-07-19 Nmt Medical, Inc. Catch members for occluder devices
US8870913B2 (en) 2006-03-31 2014-10-28 W.L. Gore & Associates, Inc. Catch system with locking cap for patent foramen ovale (PFO) occluder
US20070270905A1 (en) * 2006-05-18 2007-11-22 Cook Incorporated Patent foramen ovale closure device and method
AU2007257785B2 (en) * 2006-06-09 2013-05-02 Cardinal Health 529, Llc Single disc occlusionary patent foramen ovale closure device
US9138208B2 (en) 2006-08-09 2015-09-22 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US20080039743A1 (en) * 2006-08-09 2008-02-14 Coherex Medical, Inc. Methods for determining characteristics of an internal tissue opening
US8529597B2 (en) * 2006-08-09 2013-09-10 Coherex Medical, Inc. Devices for reducing the size of an internal tissue opening
US8075576B2 (en) * 2006-08-24 2011-12-13 Boston Scientific Scimed, Inc. Closure device, system, and method
US20080215089A1 (en) * 2006-09-21 2008-09-04 Williams Michael S Stomach wall closure devices
US8029532B2 (en) * 2006-10-11 2011-10-04 Cook Medical Technologies Llc Closure device with biomaterial patches
EP1923019B1 (en) * 2006-11-20 2010-10-20 SeptRx, Inc. Device for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool
US8784439B1 (en) * 2006-11-28 2014-07-22 Stephen V. Ward Percutaneous medical procedures and devices for closing vessels using mechanical closures
WO2008094706A2 (en) * 2007-02-01 2008-08-07 Cook Incorporated Closure device and method of closing a bodily opening
US8617205B2 (en) 2007-02-01 2013-12-31 Cook Medical Technologies Llc Closure device
US9005242B2 (en) 2007-04-05 2015-04-14 W.L. Gore & Associates, Inc. Septal closure device with centering mechanism
US9138562B2 (en) 2007-04-18 2015-09-22 W.L. Gore & Associates, Inc. Flexible catheter system
US8734483B2 (en) * 2007-08-27 2014-05-27 Cook Medical Technologies Llc Spider PFO closure device
US8308752B2 (en) * 2007-08-27 2012-11-13 Cook Medical Technologies Llc Barrel occlusion device
US20090062838A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider device with occlusive barrier
US8025495B2 (en) * 2007-08-27 2011-09-27 Cook Medical Technologies Llc Apparatus and method for making a spider occlusion device
WO2009028285A1 (en) * 2007-08-28 2009-03-05 Terumo Kabushiki Kaisha Device for opening/closing biological tissue
WO2009046441A1 (en) * 2007-10-05 2009-04-09 Coaptus Medical Corporation Systems and methods for transeptal cardiac procedures
US20130165967A1 (en) 2008-03-07 2013-06-27 W.L. Gore & Associates, Inc. Heart occlusion devices
US8177836B2 (en) * 2008-03-10 2012-05-15 Medtronic, Inc. Apparatus and methods for minimally invasive valve repair
DE102008013860A1 (en) 2008-03-12 2009-09-24 Siemens Aktiengesellschaft Catheter device for treatment of septum of heart, has coupling device arranged at proximal end in proximity of catheter tip to transport and position occluder, where sensor is provided in area of catheter tip for imaging
FR2930137B1 (en) * 2008-04-18 2010-04-23 Corevalve Inc TREATMENT EQUIPMENT FOR A CARDIAC VALVE, IN PARTICULAR A MITRAL VALVE.
WO2009132111A1 (en) * 2008-04-23 2009-10-29 Wilson-Cook Medical Inc. Tacking device
US20090292309A1 (en) * 2008-05-20 2009-11-26 Michael Maschke System and workflow for diagnosing and treating septum defects
US8333788B2 (en) * 2008-10-09 2012-12-18 Covidien Lp Knotted suture end effector
US8323316B2 (en) * 2008-10-09 2012-12-04 Covidien Lp Knotted suture end effector
US20100241140A1 (en) * 2009-03-18 2010-09-23 Medtronic, Inc. Medical Clip with Bridge, System and Method of Using Same
US8668704B2 (en) * 2009-04-24 2014-03-11 Medtronic, Inc. Medical clip with tines, system and method of using same
US20120029556A1 (en) 2009-06-22 2012-02-02 Masters Steven J Sealing device and delivery system
US9636094B2 (en) 2009-06-22 2017-05-02 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10092427B2 (en) 2009-11-04 2018-10-09 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US9649211B2 (en) 2009-11-04 2017-05-16 Confluent Medical Technologies, Inc. Alternating circumferential bridge stent design and methods for use thereof
US10743854B2 (en) 2010-01-20 2020-08-18 Micro Interventional Devices, Inc. Tissue closure device and method
CA2825186A1 (en) 2010-01-20 2011-07-28 Michael P. Whitman Tissue repair implant and delivery device and method
US9980708B2 (en) 2010-01-20 2018-05-29 Micro Interventional Devices, Inc. Tissue closure device and method
US10058314B2 (en) 2010-01-20 2018-08-28 Micro Interventional Devices, Inc. Tissue closure device and method
US10959840B2 (en) 2010-01-20 2021-03-30 Micro Interventional Devices, Inc. Systems and methods for affixing a prosthesis to tissue
US9072603B2 (en) * 2010-02-24 2015-07-07 Medtronic Ventor Technologies, Ltd. Mitral prosthesis and methods for implantation
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US8357195B2 (en) 2010-04-15 2013-01-22 Medtronic, Inc. Catheter based annuloplasty system and method
US9795482B2 (en) 2010-04-27 2017-10-24 Medtronic, Inc. Prosthetic heart valve devices and methods of valve repair
US9526483B2 (en) * 2010-07-15 2016-12-27 Medtronic Vascular Galway Apical closure system
WO2012051489A2 (en) 2010-10-15 2012-04-19 Cook Medical Technologies Llc Occlusion device for blocking fluid flow through bodily passages
EP2663244B1 (en) * 2011-01-11 2023-09-20 Amsel Medical Corporation Apparatus for securing tissue layers together
US9445898B2 (en) 2011-03-01 2016-09-20 Medtronic Ventor Technologies Ltd. Mitral valve repair
US8454656B2 (en) 2011-03-01 2013-06-04 Medtronic Ventor Technologies Ltd. Self-suturing anchors
US9770232B2 (en) 2011-08-12 2017-09-26 W. L. Gore & Associates, Inc. Heart occlusion devices
WO2013120082A1 (en) 2012-02-10 2013-08-15 Kassab Ghassan S Methods and uses of biological tissues for various stent and other medical applications
US9821145B2 (en) 2012-03-23 2017-11-21 Pressure Products Medical Supplies Inc. Transseptal puncture apparatus and method for using the same
US10828019B2 (en) 2013-01-18 2020-11-10 W.L. Gore & Associates, Inc. Sealing device and delivery system
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
US9808230B2 (en) 2014-06-06 2017-11-07 W. L. Gore & Associates, Inc. Sealing device and delivery system
US10993807B2 (en) 2017-11-16 2021-05-04 Medtronic Vascular, Inc. Systems and methods for percutaneously supporting and manipulating a septal wall
CN109247965B (en) * 2018-10-10 2021-11-26 先健科技(深圳)有限公司 Suturing device

Citations (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US4006747A (en) * 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4149327A (en) * 1976-07-21 1979-04-17 Jura Elektroapparate-Fabriken L. Henzirohs A.G. Steam iron
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4738666A (en) * 1985-06-11 1988-04-19 Genus Catheter Technologies, Inc. Variable diameter catheter
US4802478A (en) * 1982-03-04 1989-02-07 Minnesota Mining And Manufacturing Company Medical staple and removal method
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4915107A (en) * 1988-03-09 1990-04-10 Harley International Medical Ltd. Automatic instrument for purse-string sutures for surgical use
US4917089A (en) * 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US5106913A (en) * 1986-07-16 1992-04-21 Sumitomo Chemical Company, Limited Rubber composition
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5176659A (en) * 1991-02-28 1993-01-05 Mario Mancini Expandable intravenous catheter and method of using
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5304184A (en) * 1992-10-19 1994-04-19 Indiana University Foundation Apparatus and method for positive closure of an internal tissue membrane opening
US5486193A (en) * 1992-01-22 1996-01-23 C. R. Bard, Inc. System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US5507811A (en) * 1993-11-26 1996-04-16 Nissho Corporation Prosthetic device for atrial septal defect repair
US5601571A (en) * 1994-05-17 1997-02-11 Moss; Gerald Surgical fastener implantation device
US5603703A (en) * 1995-04-28 1997-02-18 Medtronic, Inc. Selectively aspirating stylet
US5618311A (en) * 1994-09-28 1997-04-08 Gryskiewicz; Joseph M. Surgical subcuticular fastener system
US5620461A (en) * 1989-05-29 1997-04-15 Muijs Van De Moer; Wouter M. Sealing device
US5649977A (en) * 1994-09-22 1997-07-22 Advanced Cardiovascular Systems, Inc. Metal reinforced polymer stent
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US5713864A (en) * 1995-04-11 1998-02-03 Sims Level 1, Inc. Integral conductive polymer resistance heated tubing
US5717259A (en) * 1996-01-11 1998-02-10 Schexnayder; J. Rodney Electromagnetic machine
US5720754A (en) * 1989-08-16 1998-02-24 Medtronic, Inc. Device or apparatus for manipulating matter
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5741297A (en) * 1996-08-28 1998-04-21 Simon; Morris Daisy occluder and method for septal defect repair
US5855614A (en) * 1993-02-22 1999-01-05 Heartport, Inc. Method and apparatus for thoracoscopic intracardiac procedures
US5861003A (en) * 1996-10-23 1999-01-19 The Cleveland Clinic Foundation Apparatus and method for occluding a defect or aperture within body surface
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5879366A (en) * 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
US5893856A (en) * 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US6010517A (en) * 1996-04-10 2000-01-04 Baccaro; Jorge Alberto Device for occluding abnormal vessel communications
US6019753A (en) * 1997-12-02 2000-02-01 Smiths Industries Public Limited Company Catheter assemblies and inner cannulae
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
WO2000007506A2 (en) * 1998-08-03 2000-02-17 Anson Medical Ltd. Devices and methods for the repair of arteries
US6027519A (en) * 1997-12-15 2000-02-22 Stanford; Ulf Harry Catheter with expandable multiband segment
US6030007A (en) * 1997-07-07 2000-02-29 Hughes Electronics Corporation Continually adjustable nonreturn knot
US6168588B1 (en) * 1995-12-12 2001-01-02 Medi-Dyne Inc. Overlapping welds for catheter constructions
US6171329B1 (en) * 1994-12-19 2001-01-09 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US6174322B1 (en) * 1997-08-08 2001-01-16 Cardia, Inc. Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6183443B1 (en) * 1992-10-15 2001-02-06 Scimed Life Systems, Inc. Expandable introducer sheath
US6187039B1 (en) * 1996-12-10 2001-02-13 Purdue Research Foundation Tubular submucosal graft constructs
US6190357B1 (en) * 1998-04-21 2001-02-20 Cardiothoracic Systems, Inc. Expandable cannula for performing cardiopulmonary bypass and method for using same
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US6199262B1 (en) * 1997-08-20 2001-03-13 Medtronic, Inc. Method of making a guiding catheter
US6206907B1 (en) * 1999-05-07 2001-03-27 Cardia, Inc. Occlusion device with stranded wire support arms
US6206895B1 (en) * 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6214029B1 (en) * 2000-04-26 2001-04-10 Microvena Corporation Septal defect occluder
US6217590B1 (en) * 1999-01-22 2001-04-17 Scion International, Inc. Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor
US6221092B1 (en) * 1998-03-30 2001-04-24 Nissho Corporation Closure device for transcatheter operations and catheter assembly therefor
US6334872B1 (en) * 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
US20020010481A1 (en) * 1999-12-23 2002-01-24 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US6342064B1 (en) * 1998-12-22 2002-01-29 Nipro Corporation Closure device for transcatheter operation and catheter assembly therefor
US6344049B1 (en) * 1999-08-17 2002-02-05 Scion Cardio-Vascular, Inc. Filter for embolic material mounted on expandable frame and associated deployment system
US6344048B1 (en) * 1997-07-10 2002-02-05 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US6346074B1 (en) * 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
US20020019648A1 (en) * 2000-04-19 2002-02-14 Dan Akerfeldt Intra-arterial occluder
US6348041B1 (en) * 1999-03-29 2002-02-19 Cook Incorporated Guidewire
US20020022860A1 (en) * 2000-08-18 2002-02-21 Borillo Thomas E. Expandable implant devices for filtering blood flow from atrial appendages
US20020022859A1 (en) * 1999-03-12 2002-02-21 Michael Hogendijk Catheter having radially expandable main body
US20020026208A1 (en) * 2000-01-05 2002-02-28 Medical Technology Group, Inc. Apparatus and methods for delivering a closure device
US6352552B1 (en) * 2000-05-02 2002-03-05 Scion Cardio-Vascular, Inc. Stent
US20020029048A1 (en) * 2000-09-01 2002-03-07 Arnold Miller Endovascular fastener and grafting apparatus and method
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6355052B1 (en) * 1996-02-09 2002-03-12 Pfm Produkte Fur Die Medizin Aktiengesellschaft Device for closure of body defect openings
US20020032459A1 (en) * 1990-06-20 2002-03-14 Danforth Biomedical, Inc. Radially-expandable tubular elements for use in the construction of medical devices
US20020032462A1 (en) * 1998-06-10 2002-03-14 Russell A. Houser Thermal securing anastomosis systems
US6358238B1 (en) * 1999-09-02 2002-03-19 Scimed Life Systems, Inc. Expandable micro-catheter
US20020034259A1 (en) * 2000-09-21 2002-03-21 Katsuyuki Tada Transmitter for automatically changing transmission data type within specified band
US20020035374A1 (en) * 2000-09-21 2002-03-21 Borillo Thomas E. Apparatus for implanting devices in atrial appendages
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
US6508828B1 (en) * 2000-11-03 2003-01-21 Radi Medical Systems Ab Sealing device and wound closure device
US20030023266A1 (en) * 2001-07-19 2003-01-30 Borillo Thomas E. Individually customized atrial appendage implant device
US6514515B1 (en) * 1999-03-04 2003-02-04 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
US20030028213A1 (en) * 2001-08-01 2003-02-06 Microvena Corporation Tissue opening occluder
US20030045893A1 (en) * 2001-09-06 2003-03-06 Integrated Vascular Systems, Inc. Clip apparatus for closing septal defects and methods of use
US20030050665A1 (en) * 2001-09-07 2003-03-13 Integrated Vascular Systems, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US20030055455A1 (en) * 2001-09-20 2003-03-20 Scimed Life Systems, Inc. Method and apparatus for treating septal defects
US20030059640A1 (en) * 1999-11-19 2003-03-27 Denes Marton High strength vacuum deposited nitinol alloy films and method of making same
US20030057156A1 (en) * 2001-03-08 2003-03-27 Dean Peterson Atrial filter implants
US6689589B2 (en) * 1997-09-19 2004-02-10 Metabolix, Inc. Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
US20040044361A1 (en) * 1998-11-06 2004-03-04 Frazier Andrew G.C. Detachable atrial appendage occlusion balloon
US6712836B1 (en) * 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6712804B2 (en) * 1999-09-20 2004-03-30 Ev3 Sunnyvale, Inc. Method of closing an opening in a wall of the heart
US6838493B2 (en) * 1999-03-25 2005-01-04 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US20050025809A1 (en) * 2003-07-08 2005-02-03 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20050043759A1 (en) * 2003-07-14 2005-02-24 Nmt Medical, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US6867248B1 (en) * 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6867249B2 (en) * 2000-08-18 2005-03-15 Kin Man Amazon Lee Lightweight and porous construction materials containing rubber
US20070010851A1 (en) * 2003-07-14 2007-01-11 Chanduszko Andrzej J Tubular patent foramen ovale (PFO) closure device with catch system

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4696300A (en) 1985-04-11 1987-09-29 Dennison Manufacturing Company Fastener for joining materials
US4710192A (en) 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US5478353A (en) 1987-05-14 1995-12-26 Yoon; Inbae Suture tie device system and method for suturing anatomical tissue proximate an opening
US4836204A (en) 1987-07-06 1989-06-06 Landymore Roderick W Method for effecting closure of a perforation in the septum of the heart
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US5171259A (en) 1990-04-02 1992-12-15 Kanji Inoue Device for nonoperatively occluding a defect
US5021059A (en) 1990-05-07 1991-06-04 Kensey Nash Corporation Plug device with pulley for sealing punctures in tissue and methods of use
US5037433A (en) 1990-05-17 1991-08-06 Wilk Peter J Endoscopic suturing device and related method and suture
US5041129A (en) 1990-07-02 1991-08-20 Acufex Microsurgical, Inc. Slotted suture anchor and method of anchoring a suture
US5257637A (en) 1991-03-22 1993-11-02 El Gazayerli Mohamed M Method for suture knot placement and tying
DE69226841T2 (en) 1991-11-05 1999-05-20 Childrens Medical Center Occlusion device for repairing heart and vascular defects
EP0545091B1 (en) 1991-11-05 1999-07-07 The Children's Medical Center Corporation Occluder for repair of cardiac and vascular defects
US5222974A (en) 1991-11-08 1993-06-29 Kensey Nash Corporation Hemostatic puncture closure system and method of use
JP3393383B2 (en) 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5411481A (en) 1992-04-08 1995-05-02 American Cyanamid Co. Surgical purse string suturing instrument and method
US5236440A (en) 1992-04-14 1993-08-17 American Cyanamid Company Surgical fastener
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
US5540712A (en) 1992-05-01 1996-07-30 Nitinol Medical Technologies, Inc. Stent and method and apparatus for forming and delivering the same
DE4215449C1 (en) 1992-05-11 1993-09-02 Ethicon Gmbh & Co Kg, 2000 Norderstedt, De
US5312341A (en) 1992-08-14 1994-05-17 Wayne State University Retaining apparatus and procedure for transseptal catheterization
US5417699A (en) 1992-12-10 1995-05-23 Perclose Incorporated Device and method for the percutaneous suturing of a vascular puncture site
US5312435A (en) 1993-05-17 1994-05-17 Kensey Nash Corporation Fail predictable, reinforced anchor for hemostatic puncture closure
US5480424A (en) 1993-11-01 1996-01-02 Cox; James L. Heart valve replacement using flexible tubes
US5683411A (en) 1994-04-06 1997-11-04 William Cook Europe A/S Medical article for implantation into the vascular system of a patient
US5693085A (en) 1994-04-29 1997-12-02 Scimed Life Systems, Inc. Stent with collagen
US6475232B1 (en) * 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
US5433727A (en) 1994-08-16 1995-07-18 Sideris; Eleftherios B. Centering buttoned device for the occlusion of large defects for occluding
US5577299A (en) 1994-08-26 1996-11-26 Thompson; Carl W. Quick-release mechanical knot apparatus
US5702421A (en) 1995-01-11 1997-12-30 Schneidt; Bernhard Closure device for closing a vascular opening, such as patent ductus arteriosus
US5634936A (en) 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
US5755791A (en) 1996-04-05 1998-05-26 Purdue Research Foundation Perforated submucosal tissue graft constructs
EP0900051A1 (en) 1996-05-08 1999-03-10 Salviac Limited An occluder device
US5800516A (en) 1996-08-08 1998-09-01 Cordis Corporation Deployable and retrievable shape memory stent/tube and method
US5810884A (en) 1996-09-09 1998-09-22 Beth Israel Deaconess Medical Center Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject
EP0936930B1 (en) 1996-11-05 2004-07-28 Purdue Research Foundation Myocardial graft constructs
WO1998025549A1 (en) 1996-12-10 1998-06-18 Purdue Research Foundation Artificial vascular valves
US5776162A (en) 1997-01-03 1998-07-07 Nitinol Medical Technologies, Inc. Vessel implantable shape memory appliance with superelastic hinged joint
JP3134287B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Catheter assembly for endocardial suture surgery
JP3134288B2 (en) 1997-01-30 2001-02-13 株式会社ニッショー Endocardial suture surgery tool
US5993844A (en) 1997-05-08 1999-11-30 Organogenesis, Inc. Chemical treatment, without detergents or enzymes, of tissue to form an acellular, collagenous matrix
US5902319A (en) 1997-09-25 1999-05-11 Daley; Robert J. Bioabsorbable staples
US6106913A (en) 1997-10-10 2000-08-22 Quantum Group, Inc Fibrous structures containing nanofibrils and other textile fibers
US5989268A (en) 1997-10-28 1999-11-23 Boston Scientific Corporation Endoscopic hemostatic clipping device
US5976174A (en) 1997-12-15 1999-11-02 Ruiz; Carlos E. Medical hole closure device and methods of use
US5944738A (en) 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
US5993475A (en) 1998-04-22 1999-11-30 Bristol-Myers Squibb Co. Tissue repair device
US6113609A (en) 1998-05-26 2000-09-05 Scimed Life Systems, Inc. Implantable tissue fastener and system for treating gastroesophageal reflux disease
US6328822B1 (en) * 1998-06-26 2001-12-11 Kiyohito Ishida Functionally graded alloy, use thereof and method for producing same
US6165183A (en) 1998-07-15 2000-12-26 St. Jude Medical, Inc. Mitral and tricuspid valve repair
US5919200A (en) 1998-10-09 1999-07-06 Hearten Medical, Inc. Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter
US6152144A (en) 1998-11-06 2000-11-28 Appriva Medical, Inc. Method and device for left atrial appendage occlusion
US6228097B1 (en) * 1999-01-22 2001-05-08 Scion International, Inc. Surgical instrument for clipping and cutting blood vessels and organic structures
US6379342B1 (en) * 1999-04-02 2002-04-30 Scion International, Inc. Ampoule for dispensing medication and method of use
JP2000300571A (en) * 1999-04-19 2000-10-31 Nissho Corp Closure plug for transcatheter operation
US6379368B1 (en) * 1999-05-13 2002-04-30 Cardia, Inc. Occlusion device with non-thrombogenic properties
US6165204A (en) 1999-06-11 2000-12-26 Scion International, Inc. Shaped suture clip, appliance and method therefor
US6245080B1 (en) * 1999-07-13 2001-06-12 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US7892246B2 (en) * 1999-07-28 2011-02-22 Bioconnect Systems, Inc. Devices and methods for interconnecting conduits and closing openings in tissue
CA2381818C (en) * 1999-09-13 2009-08-04 Rex Medical, L.P. Vascular closure
US6626930B1 (en) * 1999-10-21 2003-09-30 Edwards Lifesciences Corporation Minimally invasive mitral valve repair method and apparatus
US6551303B1 (en) * 1999-10-27 2003-04-22 Atritech, Inc. Barrier device for ostium of left atrial appendage
US6387104B1 (en) * 1999-11-12 2002-05-14 Scimed Life Systems, Inc. Method and apparatus for endoscopic repair of the lower esophageal sphincter
US6551344B2 (en) * 2000-04-26 2003-04-22 Ev3 Inc. Septal defect occluder
US6334864B1 (en) * 2000-05-17 2002-01-01 Aga Medical Corp. Alignment member for delivering a non-symmetric device with a predefined orientation
US6364853B1 (en) * 2000-09-11 2002-04-02 Scion International, Inc. Irrigation and suction valve and method therefor
WO2002024114A2 (en) * 2000-09-25 2002-03-28 Cohesion Technologies, Inc. Resorbable anastomosis stents and plugs
US6375625B1 (en) * 2000-10-18 2002-04-23 Scion Valley, Inc. In-line specimen trap and method therefor
US6746404B2 (en) * 2000-12-18 2004-06-08 Biosense, Inc. Method for anchoring a medical device between tissue
US6537300B2 (en) * 2001-05-30 2003-03-25 Scimed Life Systems, Inc. Implantable obstruction device for septal defects

Patent Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US3875648A (en) * 1973-04-04 1975-04-08 Dennison Mfg Co Fastener attachment apparatus and method
US4006747A (en) * 1975-04-23 1977-02-08 Ethicon, Inc. Surgical method
US4007743A (en) * 1975-10-20 1977-02-15 American Hospital Supply Corporation Opening mechanism for umbrella-like intravascular shunt defect closure device
US4149327A (en) * 1976-07-21 1979-04-17 Jura Elektroapparate-Fabriken L. Henzirohs A.G. Steam iron
US4425908A (en) * 1981-10-22 1984-01-17 Beth Israel Hospital Blood clot filter
US4802478A (en) * 1982-03-04 1989-02-07 Minnesota Mining And Manufacturing Company Medical staple and removal method
US4738666A (en) * 1985-06-11 1988-04-19 Genus Catheter Technologies, Inc. Variable diameter catheter
US5106913A (en) * 1986-07-16 1992-04-21 Sumitomo Chemical Company, Limited Rubber composition
US4915107A (en) * 1988-03-09 1990-04-10 Harley International Medical Ltd. Automatic instrument for purse-string sutures for surgical use
US4902508A (en) * 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US4917089A (en) * 1988-08-29 1990-04-17 Sideris Eleftherios B Buttoned device for the transvenous occlusion of intracardiac defects
US5192301A (en) * 1989-01-17 1993-03-09 Nippon Zeon Co., Ltd. Closing plug of a defect for medical use and a closing plug device utilizing it
US5620461A (en) * 1989-05-29 1997-04-15 Muijs Van De Moer; Wouter M. Sealing device
US5720754A (en) * 1989-08-16 1998-02-24 Medtronic, Inc. Device or apparatus for manipulating matter
US5078736A (en) * 1990-05-04 1992-01-07 Interventional Thermodynamics, Inc. Method and apparatus for maintaining patency in the body passages
US20020032459A1 (en) * 1990-06-20 2002-03-14 Danforth Biomedical, Inc. Radially-expandable tubular elements for use in the construction of medical devices
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
US5176659A (en) * 1991-02-28 1993-01-05 Mario Mancini Expandable intravenous catheter and method of using
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5486193A (en) * 1992-01-22 1996-01-23 C. R. Bard, Inc. System for the percutaneous transluminal front-end loading delivery of a prosthetic occluder
US6183443B1 (en) * 1992-10-15 2001-02-06 Scimed Life Systems, Inc. Expandable introducer sheath
US5304184A (en) * 1992-10-19 1994-04-19 Indiana University Foundation Apparatus and method for positive closure of an internal tissue membrane opening
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US6346074B1 (en) * 1993-02-22 2002-02-12 Heartport, Inc. Devices for less invasive intracardiac interventions
US5855614A (en) * 1993-02-22 1999-01-05 Heartport, Inc. Method and apparatus for thoracoscopic intracardiac procedures
US5507811A (en) * 1993-11-26 1996-04-16 Nissho Corporation Prosthetic device for atrial septal defect repair
US6334872B1 (en) * 1994-02-18 2002-01-01 Organogenesis Inc. Method for treating diseased or damaged organs
US5601571A (en) * 1994-05-17 1997-02-11 Moss; Gerald Surgical fastener implantation device
US5725552A (en) * 1994-07-08 1998-03-10 Aga Medical Corporation Percutaneous catheter directed intravascular occlusion devices
US5649977A (en) * 1994-09-22 1997-07-22 Advanced Cardiovascular Systems, Inc. Metal reinforced polymer stent
US5618311A (en) * 1994-09-28 1997-04-08 Gryskiewicz; Joseph M. Surgical subcuticular fastener system
US6171329B1 (en) * 1994-12-19 2001-01-09 Gore Enterprise Holdings, Inc. Self-expanding defect closure device and method of making and using
US5733337A (en) * 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US5713864A (en) * 1995-04-11 1998-02-03 Sims Level 1, Inc. Integral conductive polymer resistance heated tubing
US5603703A (en) * 1995-04-28 1997-02-18 Medtronic, Inc. Selectively aspirating stylet
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US6190353B1 (en) * 1995-10-13 2001-02-20 Transvascular, Inc. Methods and apparatus for bypassing arterial obstructions and/or performing other transvascular procedures
US5709707A (en) * 1995-10-30 1998-01-20 Children's Medical Center Corporation Self-centering umbrella-type septal closure device
US6168588B1 (en) * 1995-12-12 2001-01-02 Medi-Dyne Inc. Overlapping welds for catheter constructions
US5717259A (en) * 1996-01-11 1998-02-10 Schexnayder; J. Rodney Electromagnetic machine
US6355052B1 (en) * 1996-02-09 2002-03-12 Pfm Produkte Fur Die Medizin Aktiengesellschaft Device for closure of body defect openings
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US6024756A (en) * 1996-03-22 2000-02-15 Scimed Life Systems, Inc. Method of reversibly closing a septal defect
US6010517A (en) * 1996-04-10 2000-01-04 Baccaro; Jorge Alberto Device for occluding abnormal vessel communications
US5893856A (en) * 1996-06-12 1999-04-13 Mitek Surgical Products, Inc. Apparatus and method for binding a first layer of material to a second layer of material
US5741297A (en) * 1996-08-28 1998-04-21 Simon; Morris Daisy occluder and method for septal defect repair
US5861003A (en) * 1996-10-23 1999-01-19 The Cleveland Clinic Foundation Apparatus and method for occluding a defect or aperture within body surface
US6187039B1 (en) * 1996-12-10 2001-02-13 Purdue Research Foundation Tubular submucosal graft constructs
US5879366A (en) * 1996-12-20 1999-03-09 W.L. Gore & Associates, Inc. Self-expanding defect closure device and method of making and using
US6867248B1 (en) * 1997-05-12 2005-03-15 Metabolix, Inc. Polyhydroxyalkanoate compositions having controlled degradation rates
US6030007A (en) * 1997-07-07 2000-02-29 Hughes Electronics Corporation Continually adjustable nonreturn knot
US6344048B1 (en) * 1997-07-10 2002-02-05 Scimed Life Systems, Inc. Removable occlusion system for aneurysm neck
US6174330B1 (en) * 1997-08-01 2001-01-16 Schneider (Usa) Inc Bioabsorbable marker having radiopaque constituents
US6174322B1 (en) * 1997-08-08 2001-01-16 Cardia, Inc. Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum
US6199262B1 (en) * 1997-08-20 2001-03-13 Medtronic, Inc. Method of making a guiding catheter
US6689589B2 (en) * 1997-09-19 2004-02-10 Metabolix, Inc. Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
US6019753A (en) * 1997-12-02 2000-02-01 Smiths Industries Public Limited Company Catheter assemblies and inner cannulae
US6027519A (en) * 1997-12-15 2000-02-22 Stanford; Ulf Harry Catheter with expandable multiband segment
US6221092B1 (en) * 1998-03-30 2001-04-24 Nissho Corporation Closure device for transcatheter operations and catheter assembly therefor
US6190357B1 (en) * 1998-04-21 2001-02-20 Cardiothoracic Systems, Inc. Expandable cannula for performing cardiopulmonary bypass and method for using same
US20020032462A1 (en) * 1998-06-10 2002-03-14 Russell A. Houser Thermal securing anastomosis systems
WO2000007506A2 (en) * 1998-08-03 2000-02-17 Anson Medical Ltd. Devices and methods for the repair of arteries
US20040044361A1 (en) * 1998-11-06 2004-03-04 Frazier Andrew G.C. Detachable atrial appendage occlusion balloon
US6342064B1 (en) * 1998-12-22 2002-01-29 Nipro Corporation Closure device for transcatheter operation and catheter assembly therefor
US6356782B1 (en) * 1998-12-24 2002-03-12 Vivant Medical, Inc. Subcutaneous cavity marking device and method
US6217590B1 (en) * 1999-01-22 2001-04-17 Scion International, Inc. Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor
US6514515B1 (en) * 1999-03-04 2003-02-04 Tepha, Inc. Bioabsorbable, biocompatible polymers for tissue engineering
US20020022859A1 (en) * 1999-03-12 2002-02-21 Michael Hogendijk Catheter having radially expandable main body
US6838493B2 (en) * 1999-03-25 2005-01-04 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6867247B2 (en) * 1999-03-25 2005-03-15 Metabolix, Inc. Medical devices and applications of polyhydroxyalkanoate polymers
US6348041B1 (en) * 1999-03-29 2002-02-19 Cook Incorporated Guidewire
US6206907B1 (en) * 1999-05-07 2001-03-27 Cardia, Inc. Occlusion device with stranded wire support arms
US6712836B1 (en) * 1999-05-13 2004-03-30 St. Jude Medical Atg, Inc. Apparatus and methods for closing septal defects and occluding blood flow
US6206895B1 (en) * 1999-07-13 2001-03-27 Scion Cardio-Vascular, Inc. Suture with toggle and delivery system
US6344049B1 (en) * 1999-08-17 2002-02-05 Scion Cardio-Vascular, Inc. Filter for embolic material mounted on expandable frame and associated deployment system
US6358238B1 (en) * 1999-09-02 2002-03-19 Scimed Life Systems, Inc. Expandable micro-catheter
US6712804B2 (en) * 1999-09-20 2004-03-30 Ev3 Sunnyvale, Inc. Method of closing an opening in a wall of the heart
US20030059640A1 (en) * 1999-11-19 2003-03-27 Denes Marton High strength vacuum deposited nitinol alloy films and method of making same
US20020010481A1 (en) * 1999-12-23 2002-01-24 Swaminathan Jayaraman Occlusive coil manufacture and delivery
US20020026208A1 (en) * 2000-01-05 2002-02-28 Medical Technology Group, Inc. Apparatus and methods for delivering a closure device
US20020019648A1 (en) * 2000-04-19 2002-02-14 Dan Akerfeldt Intra-arterial occluder
US6214029B1 (en) * 2000-04-26 2001-04-10 Microvena Corporation Septal defect occluder
US6352552B1 (en) * 2000-05-02 2002-03-05 Scion Cardio-Vascular, Inc. Stent
US6867249B2 (en) * 2000-08-18 2005-03-15 Kin Man Amazon Lee Lightweight and porous construction materials containing rubber
US20020022860A1 (en) * 2000-08-18 2002-02-21 Borillo Thomas E. Expandable implant devices for filtering blood flow from atrial appendages
US20020029048A1 (en) * 2000-09-01 2002-03-07 Arnold Miller Endovascular fastener and grafting apparatus and method
US20020035374A1 (en) * 2000-09-21 2002-03-21 Borillo Thomas E. Apparatus for implanting devices in atrial appendages
US20020034259A1 (en) * 2000-09-21 2002-03-21 Katsuyuki Tada Transmitter for automatically changing transmission data type within specified band
US6508828B1 (en) * 2000-11-03 2003-01-21 Radi Medical Systems Ab Sealing device and wound closure device
US20030057156A1 (en) * 2001-03-08 2003-03-27 Dean Peterson Atrial filter implants
US20030004533A1 (en) * 2001-05-04 2003-01-02 Concentric Medical Bioactive polymer vaso-occlusive device
US20030023266A1 (en) * 2001-07-19 2003-01-30 Borillo Thomas E. Individually customized atrial appendage implant device
US20030028213A1 (en) * 2001-08-01 2003-02-06 Microvena Corporation Tissue opening occluder
US20030045893A1 (en) * 2001-09-06 2003-03-06 Integrated Vascular Systems, Inc. Clip apparatus for closing septal defects and methods of use
US20030050665A1 (en) * 2001-09-07 2003-03-13 Integrated Vascular Systems, Inc. Needle apparatus for closing septal defects and methods for using such apparatus
US20030055455A1 (en) * 2001-09-20 2003-03-20 Scimed Life Systems, Inc. Method and apparatus for treating septal defects
US20050025809A1 (en) * 2003-07-08 2005-02-03 Tepha, Inc. Poly-4-hydroxybutyrate matrices for sustained drug delivery
US20050043759A1 (en) * 2003-07-14 2005-02-24 Nmt Medical, Inc. Tubular patent foramen ovale (PFO) closure device with catch system
US20070010851A1 (en) * 2003-07-14 2007-01-11 Chanduszko Andrzej J Tubular patent foramen ovale (PFO) closure device with catch system

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11369374B2 (en) 2006-05-03 2022-06-28 Datascope Corp. Systems and methods of tissue closure
US10595861B2 (en) 2006-05-03 2020-03-24 Datascope Corp. Systems and methods of tissue closure
US9375218B2 (en) 2006-05-03 2016-06-28 Datascope Corp. Systems and methods of tissue closure
US20100234878A1 (en) * 2009-03-16 2010-09-16 Cook Incorporated Closure device with string retractable umbrella
US8029534B2 (en) 2009-03-16 2011-10-04 Cook Medical Technologies Llc Closure device with string retractable umbrella
US8277482B2 (en) 2009-03-16 2012-10-02 Cook Medical Technologies Llc Closure device with string retractable umbrella and method for closing a body opening with the same
US9259290B2 (en) 2009-06-08 2016-02-16 MRI Interventions, Inc. MRI-guided surgical systems with proximity alerts
US9439735B2 (en) 2009-06-08 2016-09-13 MRI Interventions, Inc. MRI-guided interventional systems that can track and generate dynamic visualizations of flexible intrabody devices in near real time
US8886288B2 (en) 2009-06-16 2014-11-11 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8825133B2 (en) 2009-06-16 2014-09-02 MRI Interventions, Inc. MRI-guided catheters
US8768433B2 (en) 2009-06-16 2014-07-01 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8396532B2 (en) 2009-06-16 2013-03-12 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US8369930B2 (en) 2009-06-16 2013-02-05 MRI Interventions, Inc. MRI-guided devices and MRI-guided interventional systems that can track and generate dynamic visualizations of the devices in near real time
US10485545B2 (en) 2013-11-19 2019-11-26 Datascope Corp. Fastener applicator with interlock
US11564689B2 (en) 2013-11-19 2023-01-31 Datascope Corp. Fastener applicator with interlock
US11653928B2 (en) 2018-03-28 2023-05-23 Datascope Corp. Device for atrial appendage exclusion
US20210205006A1 (en) * 2020-01-07 2021-07-08 Virender K. Sharma Methods and Devices for Endoscopic Resection
EP4087507A4 (en) * 2020-01-07 2024-02-14 Virender K Sharma Methods and devices for endoscopic resection

Also Published As

Publication number Publication date
EP1471835A4 (en) 2008-03-19
US20030144694A1 (en) 2003-07-31
AU2003210510A1 (en) 2003-07-30
WO2003059152A3 (en) 2003-11-13
WO2003059152A2 (en) 2003-07-24
EP1471835A2 (en) 2004-11-03
AU2003210510A8 (en) 2003-07-30
CA2471871A1 (en) 2003-07-24
JP2005525843A (en) 2005-09-02
US7220265B2 (en) 2007-05-22

Similar Documents

Publication Publication Date Title
US7220265B2 (en) Patent foramen ovale (PFO) closure method and device
US7967840B2 (en) PFO closure device with flexible thrombogenic joint and improved dislodgement resistance
US9017373B2 (en) Septal closure devices
US7717937B2 (en) Closure devices, related delivery methods and tools, and related methods of use
US20040143294A1 (en) Septal stabilization device
AU2007303461B2 (en) Single disc intraluminal fixation patent foramen ovale closure device
US20040098121A1 (en) Patent foramen ovale (PFO) closure with magnetic force
JP2009512521A (en) Radiopaque bioabsorbable occluder

Legal Events

Date Code Title Description
AS Assignment

Owner name: W.L. GORE & ASSOCIATES, INC., ARIZONA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NMT MEDICAL, INC. (BY AND THROUGH JOSEPH F. FINN, JR., AS ASSIGNEE FOR THE BENEFIT OF CREDITORS OF NMT MEDICAL, INC.);REEL/FRAME:026503/0273

Effective date: 20110616

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION